Journal of Pharmacology and Pharmacotherapeutics

CASE REPORT
Year
: 2014  |  Volume : 5  |  Issue : 3  |  Page : 214--216

Angioedema due to fixed dose combination of telmisartan plus ramipril


Vishal R Tandon1, Annil Mahajan2, Vijay Khajuria1, Zahid H Gillani1 
1 Department of Pharmacology and Therapeutic, Government Medical College, Jammu, Jammu and Kashmir, India
2 Department of General Medicine, Government Medical College, Jammu, Jammu and Kashmir, India

Correspondence Address:
Vishal R Tandon
Department of Pharmacology and Therapeutic, Adverse Drug Reaction Monitoring Centre (Under PvPI), Government Medical College, Jammu - 180 001, Jammu and Kashmir
India

The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin-converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema with ARBs such as olmesartan, valsartan, losartan and telmisartan. To the best of our knowledge this is the first case report of telmisartan plus ramipril fixed dose combination leading to angioedema from India questioning the rationality of ARBs plus ACEIs combination in the treatment of hypertension.


How to cite this article:
Tandon VR, Mahajan A, Khajuria V, Gillani ZH. Angioedema due to fixed dose combination of telmisartan plus ramipril.J Pharmacol Pharmacother 2014;5:214-216


How to cite this URL:
Tandon VR, Mahajan A, Khajuria V, Gillani ZH. Angioedema due to fixed dose combination of telmisartan plus ramipril. J Pharmacol Pharmacother [serial online] 2014 [cited 2019 Dec 15 ];5:214-216
Available from: http://www.jpharmacol.com/article.asp?issn=0976-500X;year=2014;volume=5;issue=3;spage=214;epage=216;aulast=Tandon;type=0